Evidence map›Paper›PMID 35183539›Full record

ArticleNeuropharmacology2022

Sex-specific role for serotonin 5-HT

Salvador Sierra, Karan H Muchhala, Donald K Jessup, Katherine M Contreras, Urjita H Shah, David L Stevens, Jennifer Jimenez, Xiomara K Cuno Lavilla, Mario de la Fuente Revenga, Kumiko M Lippold and 7 more

Open access · greenAbstract read
In one paragraph

Article in Neuropharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Stereoselective, sex-dependent 5-HTNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Sex-specific role of the 5-HTNature communications · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Beyond the 5-HTThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2023
    Review
  14. The crosstalk between 5-HTNeuropharmacology · 2023
    Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 1 institution in 1 country.

Salvador SierraDepartment of Physiology and Biophysics, Virginia Commonwealth University School of Medicine, Richmond, VA, 23298, USA.
Karan H MuchhalaDepartment of Pharmacology and Toxicology, Virginia Commonwealth University School of Medicine, Richmond, VA, 23298, USA.
Donald K JessupDepartment of Pharmacology and Toxicology, Virginia Commonwealth University School of Medicine, Richmond, VA, 23298, USA.
Katherine M ContrerasDepartment of Pharmacology and Toxicology, Virginia Commonwealth University School of Medicine, Richmond, VA, 23298, USA.
Urjita H ShahDepartment of Physiology and Biophysics, Virginia Commonwealth University School of Medicine, Richmond, VA, 23298, USA.
David L StevensDepartment of Pharmacology and Toxicology, Virginia Commonwealth University School of Medicine, Richmond, VA, 23298, USA.
Jennifer JimenezDepartment of Physiology and Biophysics, Virginia Commonwealth University School of Medicine, Richmond, VA, 23298, USA.
Xiomara K Cuno LavillaDepartment of Physiology and Biophysics, Virginia Commonwealth University School of Medicine, Richmond, VA, 23298, USA.
Mario de la Fuente RevengaDepartment of Physiology and Biophysics, Virginia Commonwealth University School of Medicine, Richmond, VA, 23298, USA; Virginia Institute of Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond, VA, 23298, USA.
Kumiko M LippoldDepartment of Pharmacology and Toxicology, Virginia Commonwealth University School of Medicine, Richmond, VA, 23298, USA.
Shanwei ShenDepartment of Physiology and Biophysics, Virginia Commonwealth University School of Medicine, Richmond, VA, 23298, USA.
Justin L PoklisDepartment of Pharmacology and Toxicology, Virginia Commonwealth University School of Medicine, Richmond, VA, 23298, USA.
Liya Y QiaoDepartment of Physiology and Biophysics, Virginia Commonwealth University School of Medicine, Richmond, VA, 23298, USA.
William L DeweyDepartment of Pharmacology and Toxicology, Virginia Commonwealth University School of Medicine, Richmond, VA, 23298, USA.
Hamid I AkbaraliDepartment of Pharmacology and Toxicology, Virginia Commonwealth University School of Medicine, Richmond, VA, 23298, USA.
M Imad DamajDepartment of Pharmacology and Toxicology, Virginia Commonwealth University School of Medicine, Richmond, VA, 23298, USA.
Javier González-MaesoDepartment of Physiology and Biophysics, Virginia Commonwealth University School of Medicine, Richmond, VA, 23298, USA. Electronic address: javier.maeso@vcuhealth.org.
Virginia Commonwealth University · US

Funding

TRAINING IN THE PHARMACOLOGY OF ABUSED DRUGST32DA007027 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI William L. Dewey · 1985 to 2026
$14.7M
VCU Center for Drug Addiction ResearchP30DA033934 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI Matthew Sean Halquist · 2014 to 2026
$13.8M
Structure and function of the 5HT2A/mGluR2 complex in schizophreniaR01MH084894 · NIMH · VIRGINIA COMMONWEALTH UNIVERSITY · PI Javier Gonzalez-Maeso · 2009 to 2026
$6.8M
Research Training: Psychiatric &Statistical GeneticsT32MH020030 · NIMH · VIRGINIA COMMONWEALTH UNIVERSITY · PI HERMINE H MAES, MICHAEL CHURTON NEALE · 1999 to 2026
$6.7M
VCU Bridges to the Baccalaureate: From Dream to GoalR25GM102795 · NIGMS · VIRGINIA COMMONWEALTH UNIVERSITY · PI CHU, SHIJIAN, GOLDING, SARAH ELIZABETH · 2013 to 2022
$2.6M
Mechanisms of Ethanol's Reversal of Opioid ToleranceR01DA036975 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI AKBARALI, HAMID I, DEWEY, WILLIAM L. · 2014 to 2018
$2.3M
Sensory Cross-Activation in Bowel DysfunctionR01DK121131 · NIDDK · VIRGINIA COMMONWEALTH UNIVERSITY · PI QIAO, LIYA · 2022 to 2025
$1.9M
Preclinical role of HDAC2 in mGlu2-dependent schizophrenia treatmentR01MH111940 · NIMH · VIRGINIA COMMONWEALTH UNIVERSITY · PI GONZÁLEZ-MAESO, JAVIER · 2017 to 2021
$1.5M
Neuroinflammatory Regulation of Colonic Mechanosensory ActivityR01DK118137 · NIDDK · VIRGINIA COMMONWEALTH UNIVERSITY · PI QIAO, LIYA · 2019 to 2022
$1.4M
NIDA NIH HHS P30 DA033934NIDA NIH HHS R01 DA036975NIDA NIH HHS T32 DA007027NIDDK NIH HHS R01 DK118137NIDDK NIH HHS R01 DK121131NIGMS NIH HHS R25 GM102795NIMH NIH HHS R01 MH084894NIMH NIH HHS R01 MH111940NIMH NIH HHS T32 MH020030
6 · The paper itself

Abstract

Opioids are among the most effective analgesics and the mainstay of pain management. However, concerns about safety and abuse liability have challenged their widespread use by the medical community. Opioid-sparing therapies include drugs that in combination with opioids have the ability to enhance analgesia while decreasing opioid requirement as well as their side effects. Sex differences in antinociceptive responses to opioids have received increasing attention in recent years. However, the molecular mechanisms underlying sex differences related to opioid-sparing adjuncts remain largely unexplored. Using warm water tail-withdrawal as a mouse model of acute thermal nociception, our data suggest that adjunctive administration of the serotonin 5-HT

Indexed as

Analgesics, OpioidOxycodoneAnimalsFemaleMaleMiceReceptor, Serotonin, 5-HT2ARewardSerotoninAnalgesics, OpioidOxycodoneReceptor, Serotonin, 5-HT2ASerotoninAnalgesiaAntinociceptionG protein-coupled receptor (GPCR)Non-opioid adjuvantOpioid receptorOxycodonePainSerotonin 5-HT(2A) receptorSubstance use disorder

Identifiers

PMID35183539
PMCPMC8934299
OpenAlexW4212990475

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.